Generic semaglutide is a once-weekly injectable medicine for adults with type 2 diabetes. It contains the same active ingredient and the same amino acid sequence as branded semaglutide products such as Ozempic, which is made by Novo Nordisk. The version PandaMeds connects you with is Semaglutide Injection from Dr. Reddy’s Laboratories, authorized by Health Canada on April 30, 2026.
Semaglutide belongs to a class of drugs called GLP-1 receptor agonists. It copies a hormone your gut releases after you eat. That hormone prompts the pancreas to release insulin when blood sugar is high, slows how fast the stomach empties, and helps bring blood sugar down. Because it is dispensed through our Canadian pharmacy network rather than a US retail pharmacy, the cash price tends to land well below what most Americans pay at home.
What it treats
Semaglutide Injection is approved to improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise. A prescriber may use it on its own when metformin is not tolerated or not appropriate, or together with other diabetes medicines such as metformin, a sulfonylurea, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, or basal insulin.
A few limits are worth knowing. This product is not insulin and is not a substitute for it. It is not for type 1 diabetes or diabetic ketoacidosis. It has not been studied with short-acting (mealtime) insulin or alongside other GLP-1 drugs.
Many people taking semaglutide also lose weight, and decreased appetite and weight loss show up among its common effects. Weight loss on its own, though, is not an approved use for this particular product. The branded semaglutide approved for chronic weight management is Wegovy. If weight management is your goal, talk to your prescriber about which product fits.
Dosing and dose escalation schedule
Semaglutide follows a slow step-up schedule, which keeps stomach side effects in check while your body adjusts.
The starting dose is 0.25 mg once a week for four weeks. The 0.25 mg dose is a starter dose, not a treatment dose, so it is meant to get you going rather than to manage blood sugar on its own.
After those first four weeks, the dose moves up to 0.5 mg once weekly. If you need more blood sugar control after at least another four weeks, a prescriber may raise it to 1 mg weekly, and later to 2 mg weekly if needed.
The maximum is 2 mg once weekly.
One note specific to the Dr. Reddy’s pens: they deliver up to 1 mg per dose, so reaching a full 2 mg weekly dose calls for a different product.
You can inject on any day of the week, with or without food, as long as you leave at least 48 hours between doses. Rotate the site each time among the abdomen, thigh, or upper arm.
Missed a dose?
Take it as soon as you can within five days of the missed dose. If more than five days have gone by, skip it and pick back up on your usual day. Do not double up to make up for a missed week.
Common side effects
Most side effects are stomach-related, tend to be mild to moderate, and usually ease as your body gets used to the medicine. The most frequent ones include:
- Nausea
- Diarrhea
- Vomiting
- Stomach pain, bloating, and constipation
- Indigestion, heartburn (GERD), and burping
- Headache, dizziness, and tiredness
- Decreased appetite and weight loss
- Low blood sugar, mainly when semaglutide is taken with a sulfonylurea or insulin
Serious side effects
Get medical help right away if you notice any of the following:
- Severe, ongoing pain in your upper stomach, with or without vomiting, which can be a sign of pancreatitis.
- Swelling of the face, lips, tongue, or throat, trouble breathing or swallowing, a severe rash, or a racing heartbeat, which can signal a severe allergic reaction.
- Upper-stomach pain, fever, or yellowing of the skin or eyes, which can point to gallbladder problems.
- Reduced urination or swelling in the legs and feet. Heavy nausea, vomiting, or diarrhea can dehydrate you and strain the kidneys.
- Sudden vision changes. Semaglutide can worsen diabetic eye disease (retinopathy), and in very rare cases it has been linked to sudden vision loss from a condition called non-arteritic anterior ischemic optic neuropathy (NAION).
- Confusion, fainting, or seizures from severe low blood sugar, which is more likely if you also take other diabetes medicines.
Who should not take Semaglutide
Semaglutide carries a boxed warning about thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), based on animal studies. It is not known whether this risk carries over to people. Do not use semaglutide if you or a family member has a history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Also avoid it if you have had an allergic reaction to semaglutide or any ingredient in the product. It should not be used during pregnancy or while breastfeeding. Because semaglutide stays in the body for about a week, women planning a pregnancy should stop it at least two months ahead and use contraception while taking it.
Tell your prescriber about every medicine you take. Pairing semaglutide with insulin or a sulfonylurea raises the chance of low blood sugar, so your doctor may lower those doses. Semaglutide has not been studied in people with liver problems and should be used with caution there, and it is not recommended for end-stage kidney disease. It is not for anyone under 18.
Generic semaglutide vs. compounded semaglutide
These are not the same thing, and the difference matters. A true generic contains the same active ingredient as the brand, in the same form, and has to pass a bioequivalence review before a regulator approves it. Once the patent on a brand-name drug expires, generic makers can produce the same molecule for less because they do not repeat the original clinical trials.
Compounded semaglutide is different. Compounded versions sometimes use other salt forms, such as semaglutide sodium or semaglutide acetate, and they do not go through the same regulatory review that approved generics do. If you are comparing options, ask whether you are getting an approved generic or a compounded preparation.
Strength, ingredients, and storage
Semaglutide Injection comes as a clear, colorless solution in a pre-filled, multi-dose pen at a concentration of 1.34 mg/mL. The 2 mg pen delivers 0.25 mg or 0.5 mg doses; the 4 mg pen delivers 1 mg doses. Besides semaglutide, each milliliter contains disodium phosphate dihydrate, phenol, propylene glycol, and water for injection. The pen is not made with natural rubber latex.
Store unopened pens in the refrigerator between 2°C and 8°C until the expiry date. After first use, a pen keeps for up to eight weeks, either refrigerated or at room temperature (15°C to 30°C). Keep the cap on to protect it from light, keep it away from the cooling element, and never freeze it. If a pen has frozen, throw it out. Always remove the needle after each injection and store the pen without one attached.
Citation and Reference:
Disclaimer: This page is for informational purposes only and does not constitute medical advice. Semaglutide is a prescription medicine. Consult a licensed health care provider before starting or changing any medication. Individual results vary. All claims about clinical outcomes reference published, peer-reviewed clinical trials and publicly available regulatory data.
Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. This page is not affiliated with, endorsed by, or connected to Novo Nordisk, Apotex Inc., or Dr. Reddy’s Laboratories. Product availability, pricing, and DIN numbers are subject to change. Information is provided in good faith based on publicly available Health Canada regulatory data.
